Paid Clinical Trials and Focus Groups by Category |
|
|
|
Conditions: CDI; Clostridium Difficile Infection; Diarrhea
Intervention: Drug: CB-183,315
Sponsor: Cubist Pharmaceuticals
Not yet recruiting - verified March 2010
Conditions: Complementary Feeding; Infant Growth
Interventions: Other: Lyophilized meat; Other: Cereal
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Kinshasa School of Public Health, Karawa, Congo; University of Zambia; INCAP, Chiimaltenango, Guatemala; Aga Khan University; University of Colorado, Denver; The University of North Carolina, Chapel Hill; University of Alabama at Birmingham; Drexel University; RTI International
Recruiting - verified March 2009
Condition: Clostridium Difficile Infection
Interventions: Drug: MIYA-BM Fine Granules (CBM588); Drug: Placebo Fine Granules (without CBM588)
Sponsor: Osel, Inc.
Recruiting - verified February 2010
Condition: Diarrhea
Interventions: Procedure: Colonoscopy; Procedure: Confocal Laser Endomicroscopy
Sponsor: University of Erlangen-Nürnberg Medical School
Recruiting - verified February 2010
Conditions: Diarrhea; Acute Respiratory Infection
Interventions: Dietary Supplement: milk supplement 1; Dietary Supplement: milk supplement 2
Sponsors: Nestlé Nutrition Corporate; University of the Philippines
Not yet recruiting - verified February 2010
Conditions: Chronic Diarrhea; Abdominal Pain; Bloating
Interventions: Drug: Tinidazole and Albendazole; Drug: Placebo control
Sponsor: Sheba Medical Center
Not yet recruiting - verified February 2010
Conditions: Inflammation; Colon, Irritable; Colonic Diseases, Functional; Irritable Bowel Syndrome
Intervention:
Sponsors: The University of North Carolina, Chapel Hill; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified February 2010
Condition: Colon, Irritable
Intervention:
Sponsors: The University of North Carolina, Chapel Hill; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified February 2010
Condition: Diarrhea
Interventions: Biological: Heat-Labile Enterotoxin of E. coli (LT); Biological: Placebo
Sponsor: Intercell USA, Inc.
Recruiting - verified February 2010
Condition: Exercise Induced Asthma
Interventions: Drug: Budesonide/Formoterol; Drug: Budesonide
Sponsors: Children's Hospital Boston; Brigham and Women's Hospital
Recruiting - verified February 2010
Conditions: Dysentery; Shigella; Diarrhea
Interventions: Biological: WRSS1 vaccine candidate; Biological: Placebo vaccine
Sponsors: U.S. Army Medical Research and Materiel Command; Mahidol University; National Institutes of Health (NIH)
Not yet recruiting - verified March 2010
Condition: Irritable Bowel Syndrome
Interventions: Drug: 0.075 mg RVX-100; Drug: 0.125 mg RVX-100; Drug: 0.250 mg RVX-100; Drug: placebo
Sponsor: Revogenex, Inc.
Not yet recruiting - verified February 2010
Condition: Carcinoid Syndrome
Intervention: Drug: BIM 23A760
Sponsor: Ipsen
Recruiting - verified February 2010
Condition: Recurrent Grade IV Malignant Glioma
Intervention: Drug: Panitumumab in Combination with Irinotecan
Sponsors: Duke University; Amgen
Recruiting - verified February 2010
Condition: Breast Cancer
Interventions: Other: Side-effect questionnaires; Other: research blood samples
Sponsors: University of Chicago; Translational Breast Cancer Reserach Consortium; National Institutes of Health (NIH)
Recruiting - verified February 2010
Condition: Irritable Bowel Syndrome
Intervention: Biological: Probiotic
Sponsors: Baylor College of Medicine; National Institute of Nursing Research (NINR); University of Washington
Recruiting - verified March 2010
Conditions: Zinc Deficiency; Diarrhea; Malaria
Interventions: Dietary Supplement: Preventive zinc supplement; Dietary Supplement: Preventive placebo supplement; Dietary Supplement: Therapeutic zinc supplement; Dietary Supplement: Low-dose therapeutic zinc supplement; Other: Non-Intervention
Sponsors: University of California, Davis; Institut de Recherche en Sciences de la Sante, Bobo-Dioulasso; Helen Keller International; Thrasher Research Fund
Not yet recruiting - verified February 2010
Condition: Malnutrition
Interventions: Dietary Supplement: LNS containing 5 or 10 mg of zinc; Dietary Supplement: LNS containing 0 mg of zinc; Dietary Supplement: Placebo supplement; Dietary Supplement: Zinc supplement
Sponsors: University of California, Davis; Institut de Recherche en Sciences de la Sante, Bobo-Dioulasso; Helen Keller International
Not yet recruiting - verified February 2010
Condition: Healthy
Interventions: Dietary Supplement: diet enriched with industrial trans fatty acids; Dietary Supplement: diet enriched with ruminant trans fatty acids; Dietary Supplement: diet without any trans fatty acids
Sponsors: University Hospital Inselspital, Berne; Forschungsanstalt Agroscope Liebefeld-Posieux ALP; CTU Bern, Clinical Trials Unit, Bern; Schweizer Herzstiftung; Bundesamt für Landwirtschaft; Emmi Schweiz AG
Recruiting - verified February 2010
Condition: Diarrhea
Intervention: Drug: lanreotide
Sponsor: Ipsen
Recruiting - verified February 2010
Condition: Carcinoid Syndrome
Interventions: Drug: lanreotide; Drug: placebo
Sponsors: Tercica; Ipsen
Recruiting - verified March 2010
Conditions: Cholera; Diarrhea
Interventions: Biological: Bivalent killed oral cholera vaccine; Biological: Placebo
Sponsors: International Vaccine Institute; Shantha Biotechnics Limited; Christian Medical College, Vellore, India
Not yet recruiting - verified March 2010
Condition: Gastroenteritis
Interventions: Drug: Lacidophil (experimental high dose); Drug: Lacidophil (experimental standard dose); Drug: Placebo
Sponsor: The Hospital for Sick Children
Recruiting - verified February 2010
Condition: Antibiotic-Associated Diarrhea
Intervention: Biological: Culturelle
Sponsor: Fargo VA Medical Center
Not yet recruiting - verified February 2010
Condition: Neoplasms
Intervention: Drug: BIBW 2992
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Conditions: Cholera; Vibrio Infections; Diarrhea
Interventions: Biological: CholeraGarde®; Biological: Placebo
Sponsors: International Vaccine Institute; Avant Immunotherapeutics; Siriraj Hospital
Not yet recruiting - verified March 2010
Condition: Escherichia Coli Infections
Interventions: Drug: Ciprofloxacin 500 mg; Biological: Peru-15-pCTB; Drug: Placebo
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Condition: Chronic Bronchitis
Interventions: Drug: Avelox (Moxifloxacin, BAY12-8039); Drug: Amoxicillin clavulanic acid
Sponsor: Bayer
Recruiting - verified March 2010
Condition: Diarrhea Predominant Irritable Bowel Syndrome
Intervention: Other: Very low carbohydrate diet
Sponsor: The University of North Carolina, Chapel Hill
Not yet recruiting - verified June 2009
Condition: Prostatic Hyperplasia
Interventions: Drug: Polyphenon E, 200 mg EGCG bid; Drug: placebo
Sponsors: H. Lee Moffitt Cancer Center and Research Institute; National Cancer Institute (NCI)
Recruiting - verified February 2010
Conditions: Cholera; Diarrhea; Vibrio Infections
Interventions: Biological: Bivalent killed oral cholera vaccine; Biological: Killed Escherichia coli K12 placebo
Sponsors: International Vaccine Institute; Indian Council of Medical Research; National Institute of Cholera and Enteric Diseases, India; Shantha Biotechnics Limited
Recruiting - verified March 2010
Conditions: Abdominal Pain; Irritable Bowel Syndrome
Intervention: Behavioral: Elimination Diet
Sponsors: Baylor College of Medicine; National Institute of Nursing Research (NINR)
Recruiting - verified March 2010
Condition: Norovirus
Interventions: Biological: Norwalk Virus; Drug: Placebo
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
All Categories ... by Medical Condition » ... Diarrhea 
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
